China Universal Asset Management Company’s Eupraxia Pharmaceuticals EPRX Stock Holding History

China Universal Asset Management Company’s Portfolio EPRX Stock Details EPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.6K	Buy	12,500 +2,500	+25%	+$17.2K	﹤0.01%	429
2026 Q1	$72.4K	Buy	+10,000	New	+$80.5K	0.01%	436

Other funds holding EPRX

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

TWA

TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return

China Universal Asset Management Company's EPRX Position: Q2 2026 in Review

China Universal Asset Management Company increased its Eupraxia Pharmaceuticals (EPRX) stake by 25% in Q2 2026, buying an estimated $17.2K and bringing the position to 12,500 shares worth $82.6K. The position accounts for ﹤0.01% of the portfolio, ranked #429.

China Universal Asset Management Company first reported a position in EPRX in Q1 2026 and has held it in 2 quarters since. 3 funds tracked by Wall St. Rank hold EPRX as of Q2 2026.

China Universal Asset Management Company held 12,500 shares of Eupraxia Pharmaceuticals worth $82.6K as of Q2 2026.
China Universal Asset Management Company bought 2,500 Eupraxia Pharmaceuticals shares in Q2 2026, an estimated $17.2K.
Eupraxia Pharmaceuticals made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #429 holding.
China Universal Asset Management Company first reported a position in Eupraxia Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
3 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.